In This Issue...  by O'Keefe, E.J.
We recognize with appreciatioll Scherillg COIpornlioll Jor pledgillg support to 
tIle Etidolll fll elll Flllld Jor The Journal of Investigative Dermatology. 
which 1IIi11 be IIsed to sllpport the groll'tli alld cOlllilllled sliccess oj the 
101lnlll l. This slIpport ",ill certa;'lly slrclIgthclI all d PClpctllate the partller-
ship belll/eell the phll/"II/<lcelltical illdllstlY <lud 1)(ls;c <llld e1illical illvest\gntors 
ill cutaneOIiS biology. 
In This Issue . • • 
ACKNOWLEDGMENT 
We salllte Scherillg Corporntioll Jor their contribul.;o/1 1.0 the Eniloll!lIlelll. 
Flllld <llld Jor their COl/til/lied SIIPpOl1 oj clillical al/d illvest\gatilJc dCl7llatology. 
EJ. O'KeeJe, Chapel Hill, NC 
ANew Role for Langerhans Cells: Induction of Immunity Mediated by Cytotoxic T Lymphocytes 
Because cytotoxic T lymphocytes (CTLs) bearing the CDS antigen 
are involved in the host defense against tumors, the abi]jty to 
lti.mulate immunity involving CTLs would be a useful strategy in 
crearing anti- tumor vaccines. Such vaccines would need to employ 
lome mecharusm for increasing the nllmber of CTLs directed 
agains t specific antigens . In this isslIe (p. 718), CeIluzzi and Falo 
demon strate that Langerhans cells can stimulate potent CTL-
mediated immune responses ,I/ld thus ma y be an important target 
for strategies of vaccination. Dendritic cells, "professional" antigen 
presenting cells, are found throughout the body in both lymphoid 
and non-lymphoid tissues. By presenting antigen to the immune 
system in association with other "costimulatory" signals, they can 
ltimulate T cells to attack cells bearing the antigen they present. 
Although it is well established that epidermal dendritic cells, or 
Langerhans cells, can efIiciently present antigens to stimulate helper 
T-cell immunity and may play an important role in tumor surveil-
lance, tlleir capacity to induce tUJllor-specilic CTL immunity has 
not been studied. 1t would be important to be able to stimulate 
CTLs, since unlike helper T cells, which recognize exogenous 
antigens, CTLs are able to recognize antigen synthesized by the 
cell, such as tUlllor or viral antigens. In order to address tlus 
problem , Celluzzi and Falo exposed dendritic cells derived from 
the epidermis to an autigeruc peptide and then injected the cells 
subcutaneously into mice. Mice that had received the antigen-
loaded Langerhans cells were effectively immunized, since they 
could reject melanoma cells. Tlus immunity depended on CTLs. If 
Langerhans cells can be used to induce antigen-specific CTL-
mediated immunity, it may be possible to vaccinate against viruses 
and tumors by targeting antigens to these epidermal dendritic cells. 
Hail' Follicles-A Reservoir for Papillomaviruses? 
Boxman ct al (p. 712) have identified a likely reservoir for human 
papilloma viruses (HPV) associated with skin cancer in renal trans-
plant recipients. The earliest evidence for tile involvement of 
specific types of HPV in human skin cancer came from studies in 
patients with epidermodysplasia verruciformis (EV), a rare heredi-
cary disease. The cottontail rabbit papillomavirus has been used as 
a model of viraJ ly indu ced skin cancer since tlle seminal work of 
Shope and Hurst in 1933. The primary target cells for the rabbit 
papilloITIavirus are thought to be kel'atinocyte stem cells in hair 
follicles. Boxman e/ al therefore asked whethel' EV-associated HPVs 
might similarly be found in human hair follicles. With a nested 
polymerase chain reaction (PCR) approach designed to detect all 
known types of HPV associated "vith EV, the authors found that 
EV-HPV DNA was present in plucked hairs of all the renal 
transplant patients they tested. They were even more surprised to 
find that DNA of EV-HPV was also present in plucked hairs from 
a substantial proportion of non-immunosuppressed controls. These 
findings suggest that EV-HPV is latent in the skin of the general 
population. The lugh prevalence of HPV DNA in hairs from 
transplant recipients may be a result of ilnmunosuppression, wluch 
lIlay lea d to reactivation of latent HPV infection. The precise 
location of the HPV DNA remains to be determined. Meanwhile, 
the methodology of Box man el ai, by which papillomavirus DNA is 
detected in plucked hairs with nested PCR, may be useful for 
collection of data for epidemiologic studies. 
Is There a Systemic Antitumor Response in Cutaneous T-Cell Lymphoma? 
Asadullah c/ al (p. 743) have found that T cells are activated in 
cu taneous T-cell lymphoma (CTCL) and tllat the number of 
Icrivated cells in the peripheral blood corresponds with the stage of 
me disease. The prognosis of ca ncerS is thought to be largely 
dependent on how the tumor is handled by the immune system (by 
"rumor sllrveillance"). In CTCL, CDS+ T cells that infiltrate 
cutaneous tumors are thought to be evidence for a local anti-tumor 
immune response, but the disease is t110ught to be systemic even in 
its early stages. Ln order to look for a systemic anti-tumor response, 
the autllOrs exa mined T-cell activation and natural killer cells in the 
blood of patients with CTCL by staining for markers identifying 
these cells . They found marked T-cell activation (HLA-DR +, 
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